Teach me pft explaining every concept of it and itsvreadings in various conditions
pulmonary function test spirometry lung volumes diagram

A clinical photograph illustrating a patient performing a Pulmonary Function Test (PFT) via spirometry in a clinical or research setting. The image depicts an older adult male seated upright, wearing a nose clip to ensure mouth-only breathing. He is actively interacting with a handheld spirometer, holding the disposable mouthpiece with both hands to maintain a tight seal. The device is connected via a data cable to a computer system, which includes a monitor displaying an active interface, likely for real-time visualization of flow-volume loops and spirograms. On the desk, several replacement white cylindrical mouthpieces and the hardware interface are visible. This visual serves as an educational example of the standardized setup for measuring lung volumes and ventilation capacities, such as Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1), highlighting the necessary equipment and proper patient positioning during the procedure.

This clinical photograph illustrates the performance of a pulmonary function test, specifically Forced Vital Capacity (FVC) measurement, in an aquatic sports setting. A young male subject, wearing a blue swimming cap and dark shorts, is seated while performing spirometry. He is using a handheld digital spirometer (Pocket Spiro USB-100), gripping the white device with both hands. The subject’s lips are tightly sealed around a disposable cylindrical mouthpiece, and a nose clip is applied to ensure isolated oral expiration. A data cable connects the spirometer to a laptop on a nearby table, indicating real-time data acquisition and flow-volume loop analysis. The background shows a swimming pool environment, suggesting clinical research into the respiratory physiology of swimmers or the impact of aquatic training on lung volumes. This image serves as an educational example of portable spirometry application and proper patient positioning for diagnostic respiratory maneuvers outside a traditional lab setting.

A clinical photograph depicting a pediatric patient using a handheld peak flow monitor (spirometry device) in a community or home setting. The central figure is a young girl performing a pulmonary function test; she has a blue circular mouthpiece sealed over her lips and a light blue nose clip applied to prevent nasal airflow. She holds the gray cylindrical handle of the device, which is connected by a coiled black cable to an unseen recording base. Surrounding her are other children observing the procedure. This image illustrates the practical application of respiratory diagnostic tools in community health or clinical research settings, specifically focusing on asthma management and the assessment of Peak Expiratory Flow (PEF). The clinical significance relates to monitoring airway obstruction and lung capacity in pediatric populations.

This composite of clinical photographs illustrates three standard methods for assessing physical performance and physiological capacity in a laboratory setting. Top Left: A participant undergoes maximal isometric strength measurement using an arm extension dynamometer. The subject is seated with the upper limb secured to a mechanical lever arm equipped with force transducers to quantify torque and muscular exertion. Top Right: A measurement of pulmonary function (spirometry) is shown. The participant uses a handheld spirometer with a nose clip to ensure isolated oral airflow, measuring lung volumes and capacities such as FVC and FEV1. Bottom: The participant is engaged in an anaerobic capacity assessment via a Wingate anaerobic test. This involves high-intensity cycling on a specialized ergometer to measure peak power, anaerobic fatigue, and total anaerobic work. These tests are essential in sports medicine and exercise physiology for evaluating cardiovascular fitness, neuromuscular strength, and metabolic efficiency.

This composite medical image presents diagnostic findings for airway evaluation, consisting of a chest radiograph and a pulmonary function test graph. Image A is a posterior-anterior (PA) chest radiograph demonstrating hyperinflated lung fields characterized by increased radiolucency and flattened diaphragms, while the mediastinal contour and heart size appear within normal limits. Image B is a flow-volume loop from a spirometry assessment. The graph shows a characteristic flattening of both the expiratory (upper) and inspiratory (lower) limbs of the loop, resulting in a rectangular appearance rather than the typical triangular peak. This 'box-like' morphology is a classic physiological sign of a fixed large airway obstruction, such as subglottic stenosis or a tracheal mass. Key data points on the graph include Forced Expiratory Flow (FEF) at 25%, 50%, and 75% of vital capacity, and Peak Expiratory Flow Rate (PEFR). The clinical significance lies in the correlation between radiographic signs of air trapping and the physiological evidence of impaired airflow in both phases of respiration, facilitating the diagnosis of upper airway pathology.

This composite educational graphic illustrates the diagnostic workup of a pulmonary nodule. Panel A is a posterior-anterior (PA) chest X-ray showing a focal, rounded opacity in the right mid-to-lower lung field, demarcated by a white circle. Panel B presents an axial high-resolution computed tomography (CT) slice of the chest, providing superior anatomical detail of the same nodule (circled), revealing its irregular morphology and heterogeneous density within the pulmonary parenchyma. Panel C details Pulmonary Function Test (PFT) results, featuring a flow-volume loop and bar graphs of lung volumes. The flow-volume loop shows a blunted expiratory limb and a shift toward higher volumes, while the bar graphs compare reference values to measured Total Lung Capacity (TLC), Expiratory Reserve Volume (ERV), and Residual Volume (RV). Accompanying data shows an elevated RV and SVC (115%), suggesting air trapping or expiratory muscle weakness. This image set is designed to teach the correlation between different thoracic imaging modalities and the physiologic assessment of lung function in patients with pulmonary lesions.
flow volume loop obstructive restrictive pattern spirometry

Summary : This figure presents eight typical flow–volume loop configurations, each illustrating a different pattern of pulmonary function abnormality, including normal, obstructive, restrictive, and mixed disorders. flow–volume loop plots: # Title & Axes : • Figure title: "Examples of typical flow–volume loop configurations for a) normal, b) mild–moderate obstruction, c) severe obstruction, d) variable extrathoracic obstruction, e) fixed large/central airway obstruction, f) unilateral mainstem bronchial obstruction, g) restriction and h) mixed disorder." • X-axis: "Volume (L)" with tick labels ranging from 0 to 6 (varies by panel). • Y-axis: "Flow (L·s⁻¹)" with tick labels ranging from -10 to 10 (varies by panel). # Panels & Data Points : • Panel a) Normal: Loop with peak expiratory flow near 10 L·s⁻¹, volume up to ~6 L, smooth descending limb. • Panel b) Mild–moderate obstruction: Lower peak flow (~8 L·s⁻¹), volume up to ~4 L, scooped-out descending limb. • Panel c) Severe obstruction: Peak flow ~6 L·s⁻¹, volume up to ~2.5 L, pronounced scooping and reduced flow. • Panel d) Variable extrathoracic obstruction: Peak flow ~6 L·s⁻¹, volume up to ~4 L, plateau in inspiratory limb. • Panel e) Fixed large/central airway obstruction: Loops with both inspiratory and expiratory plateaus, volume up to ~4 L, flow range -8 to 8 L·s⁻¹. • Panel f) Unilateral mainstem bronchial obstruction: Peak flow ~3 L·s⁻¹, volume up to ~2 L, irregular loop shape. • Panel g) Restriction: Peak flow ~6 L·s⁻¹, volume up to ~2 L, steep and narrow loop. • Panel h) Mixed disorder: Peak flow ~4 L·s⁻¹, volume up to ~2 L, combination of scooping and restriction features. # Design Encodings : • Each panel shows a single blue line representing the flow–volume loop. • Axes are consistent in style, with horizontal and vertical grid lines. • No additional colour or marker encodings. # Distribution & Trends : • Normal loop (a) is tall and broad, with a rapid rise and gradual fall. • Obstructive loops (b, c) show reduced peak flow and scooped-out descending limbs. • Restrictive loop (g) is narrow and steep, with reduced volume. • Fixed obstruction (e) shows plateaus in both inspiratory and expiratory limbs. • Mixed disorder (h) combines features of obstruction and restriction. # Analysis : • The figure visually distinguishes between normal, obstructive, restrictive, and mixed pulmonary function patterns. • Obstructive patterns are characterised by reduced peak flow and scooping; restrictive patterns by reduced volume and steep loops. • Fixed and variable obstructions show plateaus, while mixed disorders combine features. • These loop shapes are diagnostic for different types of airway and lung pathology.

A multi-panel figure illustrating diagnostic findings in a patient with pulmonary and cardiovascular pathology. (a) A flow-volume loop (spirometry) showing a characteristic downward convex (scooped) expiratory limb indicative of obstructive lung disease, comparing pre-bronchodilator (black) and post-bronchodilator (green) states. (b) Axial contrast-enhanced chest CT at the level of the pulmonary arteries showing no acute thromboembolism. (c) Three-dimensional CT reconstruction of the pulmonary vasculature, with pulmonary arteries color-coded in red and pulmonary veins in blue; no pulmonary arteriovenous malformations or fistulas are identified. (d, e) Nuclear medicine ventilation-perfusion (V/Q) scintigraphy scans; the images demonstrate a V/Q mismatch without focal defects, suggesting a right-to-left shunt. Collectively, these images are used to evaluate platypnea-orthodeoxia syndrome (POS), focusing on identifying potential anatomical causes such as shunts or obstructive impairment.

A multi-panel clinical graphic illustrating the physical and diagnostic findings of Hoover's sign in a patient with airway obstruction. Panels A and B contain clinical photographs of a male patient's torso in a lateral recumbent position. Panel A (Inspiration) demonstrates a paradoxical inward retraction of the lower rib cage and intercostal spaces, a classic physical sign of diaphragmatic flattening often seen in severe COPD or emphysema. Panel B (Expiration) shows the relative expansion or outward movement of the same region. Panel C provides a spirometry data table showing an obstructive pattern: a reduced FEV1/FVC ratio (49%) and low FEF25-75% (31% of predicted). Panel D includes a flow-volume loop demonstrating characteristic expiratory flow limitation and a bar chart of lung volumes. The lung volume chart highlights significant hyperinflation and gas trapping, characterized by an elevated Residual Volume (RV) and Total Lung Capacity (TLC) compared to reference values. This composite image serves to correlate physical examination findings of abnormal chest wall dynamics with quantitative pulmonary function testing in obstructive lung disease.

This composite diagnostic image showcases 3D Magnetic Resonance (MR) Spirometry data derived from a 3D Ultra-Short Echo Time (UTE) dataset of human lungs. The figure presents three anatomical planes: coronal (top left), sagittal (top right), and axial (bottom left), captured at the end of expiration. Superimposed across the lung parenchyma are regional flow-volume loops (Q vs. J). The yellow portions of these local loops represent the inspiratory phase, while the blue segments indicate the expiratory phase. Red dots denote the specific spatial points where each local loop was measured. A green loop is included at each location as a global reference, representing the flow-volume dynamics of the entire lung. The bottom right panel provides a legend for the color-coded phases and the Q (flow) and J (volume expansion) axes. These visualizations illustrate the spatial heterogeneity and regional variability of lung ventilation and respiratory mechanics during thoracic breathing, highlighting differences in loop size and shape across different lung regions.
lung volumes TLC RV FRC spirogram diagram

Summary : This flowchart provides a decision algorithm for interpreting lung volume measurements, specifically total lung capacity (TLC), functional residual capacity (FRC), and residual volume (RV), in relation to percentiles, to classify patterns such as restriction, hyperinflation, and mixed disorders. flowchart: # Nodes : • TLC <5th percentile? (rectangle) • Restriction (rectangle) • FRC/TLC or RV/TLC >95th percentile? (rectangle) • Simple restriction (rectangle) • FEV₁/FVC <5th percentile? (rectangle) • Mixed disorder (rectangle) • Complex restriction (rectangle) • TLC >95th percentile? (rectangle) • Possible hyperinflation (rectangle) • FRC/TLC or RV/TLC >95th percentile? (rectangle) • Hyperinflation (rectangle) • Large lungs (rectangle) • FRC/TLC or RV/TLC >95th percentile? (rectangle) • Hyperinflation (rectangle) • Normal lung volumes (rectangle) # Connectors : • TLC <5th percentile? → Yes → Restriction • Restriction → FRC/TLC or RV/TLC >95th percentile? → Yes → FEV₁/FVC <5th percentile? → Yes → Mixed disorder • FEV₁/FVC <5th percentile? → No → Complex restriction • Restriction → FRC/TLC or RV/TLC >95th percentile? → No → Simple restriction • TLC <5th percentile? → No → TLC >95th percentile? • TLC >95th percentile? → Yes → Possible hyperinflation • Possible hyperinflation → FRC/TLC or RV/TLC >95th percentile? → Yes → Hyperinflation • Possible hyperinflation → FRC/TLC or RV/TLC >95th percentile? → No → Large lungs • TLC >95th percentile? → No → FRC/TLC or RV/TLC >95th percentile? • FRC/TLC or RV/TLC >95th percentile? → Yes → Hyperinflation • FRC/TLC or RV/TLC >95th percentile? → No → Normal lung volumes # Layout : • The flowchart is organized in a top-down manner, starting with TLC <5th percentile? at the top center. • The left branch (No) leads to evaluation of TLC >95th percentile? and further splits into possible hyperinflation, hyperinflation, large lungs, or normal lung volumes. • The right branch (Yes) leads to restriction, which further splits into simple restriction, complex restriction, or mixed disorder based on FRC/TLC, RV/TLC, and FEV₁/FVC values. • All nodes are rectangles; decision points are indicated by Yes/No branches. # Analysis : • The flowchart provides a systematic approach to classifying lung volume patterns based on percentile thresholds. • Restriction is identified when TLC is below the 5th percentile, with further sub-classification based on FRC/TLC, RV/TLC, and FEV₁/FVC. • Hyperinflation and large lungs are considered when TLC is above the 95th percentile or when FRC/TLC or RV/TLC exceed the 95th percentile. • The algorithm ensures that all possible outcomes (restriction, hyperinflation, mixed disorder, normal lung volumes, large lungs) are covered based on the input values.

This diagnostic image set consists of three sagittal magnetic resonance (MRI) scans of the human thorax, illustrating the relationship between the diaphragm, rib cage, and lung volumes at different respiratory stages: (a) Total Lung Capacity (TLC), (b) Functional Residual Capacity (FRC), and (c) Residual Volume (RV). The images demonstrate the mechanics of the 'zone of apposition' (ZOA)—the area where the diaphragm muscle is directly opposed to the inner rib cage. At TLC (a), the diaphragm is flattened, and the ZOA is nearly zero, with the anterior insertion (white arrowhead) close to the lower ribs (black arrows). At FRC (b) and RV (c), the diaphragm domes cranially, significantly increasing the ZOA as shown by the rising upper limits (thin white arrowheads). The scans also highlight changes in thoracic geometry; as volume decreases from TLC to RV, the rib cage descends and intercostal spaces visibly narrow. This series is an educational tool for pulmonary physiology, demonstrating diaphragmatic excursion and its contribution to inspiratory capacity.

This medical flow diagram illustrates a multi-step image registration workflow used to generate 1H-MRI-specific ventilation (SV) maps. The flowchart tracks the processing of coronal thoracic MRI slices through various respiratory states. Primary inputs include '1H MRI TLC' (Total Lung Capacity) showing expanded lung volumes and a low-riding diaphragm, and '1H MRI RV' (Residual Volume) showing contracted lung volumes with a superiorly displaced diaphragm. The workflow utilizes 'Deformable registration' to align the TLC and RV scans, resulting in a 'Warped 1H MRI TLC' image that matches the RV geometry. From these registered datasets, a '1H MRI SV map' is computed, which provides a functional representation of regional lung ventilation, appearing as a segmented intensity map. The process further incorporates functional 129Xe MRI (acquired at Functional Residual Capacity plus bag) via 'Rigid registration' to an anatomical '1H MRI FRC+bag' reference. This workflow demonstrates the integration of anatomical proton MRI and functional hyperpolarized gas MRI for advanced pulmonary diagnostic imaging and quantification of regional ventilation defects.

| Volume/Capacity | Definition | Normal value |
|---|---|---|
| Tidal Volume (TV) | Air moved in/out per normal breath at rest | ~500 mL |
| Inspiratory Reserve Volume (IRV) | Extra air you can inhale above a normal breath | ~3000 mL |
| Expiratory Reserve Volume (ERV) | Extra air you can exhale after a normal breath out | ~1200 mL |
| Residual Volume (RV) | Air remaining after maximal exhalation - cannot be measured by spirometry alone | ~1200 mL |
| Functional Residual Capacity (FRC) | Air in lungs after a normal exhale = ERV + RV | ~2400 mL |
| Inspiratory Capacity (IC) | Max air inhaled from resting position = TV + IRV | ~3500 mL |
| Vital Capacity (VC) | Max air exhaled after max inhalation = IRV + TV + ERV | ~4600 mL |
| Total Lung Capacity (TLC) | Total air the lung can hold = VC + RV | ~6000 mL |

Step 1: Is FEV1/FVC < 0.70?
YES → Obstructive pattern
NO → Normal ratio
Step 2 (if normal ratio): Is FVC < 80% predicted?
YES → Restrictive pattern (confirm with TLC < 5th percentile)
NO → Normal spirometry
Step 3: Grade severity (by FEV1 % predicted):
≥80% = Mild
50-79% = Moderate
30-49% = Severe
<30% = Very severe
| Disease | FEV1 | FVC | Ratio | TLC | RV | DLCO |
|---|---|---|---|---|---|---|
| Asthma (reversible) | ↓↓ | Normal or ↓ | ↓ | N or ↑ | ↑ | Normal |
| COPD/Emphysema | ↓↓ | ↓ | ↓ | ↑↑ | ↑↑ | ↓↓ |
| Chronic Bronchitis | ↓↓ | ↓ | ↓ | N or ↑ | ↑ | Normal |
| Bronchiectasis | ↓ | ↓ | ↓ | N or ↑ | N or ↑ | Normal or ↓ |
| Cystic Fibrosis | ↓↓ | ↓ | ↓ | ↑ | ↑↑ | ↓ |
| Disease | FEV1 | FVC | Ratio | TLC | RV | DLCO |
|---|---|---|---|---|---|---|
| Pulmonary Fibrosis (IPF) | ↓ | ↓↓ | N or ↑ | ↓↓ | ↓ | ↓↓ |
| Sarcoidosis | ↓ | ↓↓ | N or ↑ | ↓↓ | ↓ | ↓ |
| Pleural effusion | ↓ | ↓↓ | N | ↓ | ↓ | Normal |
| Kyphoscoliosis | ↓ | ↓↓ | N or ↑ | ↓↓ | ↓ | Normal |
| Neuromuscular disease | ↓ | ↓↓ | N or ↑ | ↓↓ | N or ↑ | Normal |
| Obesity | ↓ | ↓ | N | N or ↓ | N | Normal |
In neuromuscular disease, RV may be normal or elevated (patient can't exhale forcefully), while TLC is reduced - distinguishing it from true pulmonary restriction.


| Pattern | Flattening | Cause | Example |
|---|---|---|---|
| Variable Extrathoracic | Inspiratory limb only | During inspiration, negative airway pressure collapses the lesion above thoracic inlet | Vocal cord paralysis, tracheal stenosis above thorax |
| Variable Intrathoracic | Expiratory limb only | During expiration, positive pleural pressure compresses the lesion | Tracheomalacia, tracheal tumor below carina |
| Fixed Obstruction | BOTH limbs (box-shaped loop) | Rigid stenosis - not affected by breathing phase | Tracheal stenosis (rigid), goiter compressing trachea |
| Condition | DLCO | Mechanism |
|---|---|---|
| Emphysema | ↓↓ | Destruction of alveolar walls - reduced surface area |
| Pulmonary Fibrosis (IPF) | ↓↓ | Thickened alveolar-capillary membrane |
| Pulmonary Hypertension | ↓↓ | Reduced pulmonary capillary blood volume |
| Pulmonary Embolism | ↓ | Reduced capillary perfusion |
| Anemia | ↓ (corrected for Hb) | Less hemoglobin to bind CO |
| Pneumonia / Atelectasis | ↓ | Reduced available surface area |
| Sarcoidosis | ↓ | Granulomatous destruction |
| Scleroderma/ILD | ↓↓ | Membrane thickening |
| Asthma (mild) | Normal | Airway disease only, parenchyma intact |
| Polycythemia | ↑ | More hemoglobin to bind CO |
| Pulmonary hemorrhage | ↑ | Free hemoglobin in alveoli binds CO |
| Left-to-right cardiac shunt | ↑ | Increased pulmonary blood volume |
| Exercise | ↑ | Increased pulmonary blood flow and recruitment |
DLCO < 60% of predicted = increased risk of postoperative pulmonary complications - Miller's Anesthesia, p. 1304
| Feature | Asthma | COPD |
|---|---|---|
| Reversibility | Complete (FEV1 often normalizes) | Partial or absent |
| DLCO | Normal | Reduced (if emphysema) |
| TLC | Normal or ↑ | ↑↑ |
| Smoking history | Variable | Almost always |
| Age of onset | Often young | Usually >40 |

| Parameter | Obstructive | Restrictive | Mixed |
|---|---|---|---|
| PEFR | ↓↓ | Normal or ↓ | ↓ |
| FEV1 | ↓↓ | Normal or ↓ | ↓↓ |
| FVC | Normal or ↓ | ↓↓ | ↓↓ |
| FEV1/FVC | < 0.70 | > 0.80 (normal) | < 0.70 |
| TLC | N or ↑ | ↓↓ | ↓ |
| RV | ↑↑ | ↓ | Variable |
| FRC | ↑ | ↓ | Variable |
| DLCO | ↓ (emphysema) / N (bronchitis) | ↓↓ (fibrosis) / N (pleural) | ↓ |
25 ppb = likely eosinophilic inflammation; predicts steroid response
Teach me Interstitial Lung Disease
interstitial lung disease HRCT patterns honeycombing ground glass

Two high-resolution computed tomography (HRCT) axial lung window images (A and B) demonstrating interstitial lung disease (ILD) patterns with overlapping features. Case A (left) shows a combination of diffuse ground-glass opacities (GGO), particularly in the right lung, and subpleural reticulation. Peripheral honeycombing is visible in the posterior lower lung fields, creating a mixed picture of nonspecific interstitial pneumonia (NSIP) and usual interstitial pneumonia (UIP). Case B (right) reveals predominant peripheral and subpleural reticular opacities and honeycombing in the bilateral lower lobes, more pronounced on the left side, which are classic hallmarks of a UIP pattern. These images illustrate the diagnostic challenge of 'unclassifiable' or 'mixed' patterns in rheumatology-associated ILD, where inflammatory (NSIP-like) and fibrotic (UIP-like) components coexist. Key educational features include the distinction between reversible GGO and irreversible honeycombing/traction bronchiectasis in the context of progressive fibrosing interstitial lung disease (PF-ILD).

Two axial high-resolution computed tomography (HRCT) images of the thorax demonstrating patterns of interstitial lung disease, frequently associated with post-inflammatory sequelae such as those following viral pneumonia or ARDS. Image A shows bilateral, ill-defined subpleural ground-glass opacities (GGOs) primarily localized in the lower lobes. These GGOs represent a hazy increase in lung attenuation where underlying vascular structures remain visible. Image B illustrates a more diffuse distribution of ground-glass opacities across both lung fields. Associated findings include subtle interlobular septal thickening and fine reticular patterns, indicating mild interstitial involvement. No overt honeycombing, traction bronchiectasis, or dense consolidations are visualized in these specific slices. The images are pedagogically significant for distinguishing between focal subpleural and diffuse parenchymal opacification in the context of pulmonary follow-up and clinical assessment of lung parenchyma recovery.

This composite image illustrates the automated quantification of CT parenchymal patterns in a 74-year-old male with Idiopathic Pulmonary Fibrosis (IPF). Figures A and D display axial thin-section High-Resolution Computed Tomography (HRCT) images at the lung bases, showing classic signs of interstitial lung disease: peripheral honeycombing, reticulation, and ground-glass opacities (GGO). Figures B and E show the same HRCT slices with color-coded overlays generated by AI for disease pattern classification. The color map identifies honeycombing (red), reticulation (orange), ground-glass opacity (cyan), emphysema (yellow), and consolidation (dark blue), with normal lung tissue in dark green. Figure C includes a quantitative circular glyph and table summarizing the whole-lung volume (4093 cc). The data highlights the extent of lung involvement: 48% normal lung, 24% GGO, 17% reticulation, 8% emphysema, and 3% honeycombing. The glyph further breaks down these proportions by lung lobe (RUL, RML, RLL, LUL, LLL), facilitating an objective assessment of disease distribution and severity for clinical monitoring and research.

This diagnostic image is an axial High-Resolution Computed Tomography (HRCT) scan of the lung bases in a 42-year-old female patient with systemic sclerosis (SSc). The image demonstrates early-stage interstitial lung disease (ILD) characterized by subtle, patchy ground-glass opacities (GGO), indicated by black arrows. These opacities are primarily distributed in the peripheral and subpleural regions of both lungs. The ground-glass appearance is defined by a hazy increase in lung attenuation that does not obscure the underlying bronchovascular structures. Associated findings include mild reticular patterns and slight interlobular septal thickening within the affected areas. The persistence of these findings in a prone position scan (as indicated by the clinical context) suggests a non-specific interstitial pneumonia (NSIP) pattern rather than gravity-dependent atelectasis. This visual provides an educational example of the early pulmonary manifestations of connective tissue disease-associated ILD, emphasizing the importance of HRCT in detecting early interstitial alterations that may precede extensive fibrosis or honeycombing.

This composite of High-Resolution Computed Tomography (HRCT) images illustrates diverse patterns of Interstitial Lung Disease (ILD) associated with Antisynthetase Syndrome (ASyS). Panel A (axial) and B (sagittal) depict fibrotic Non-Specific Interstitial Pneumonitis (NSIP), characterized by bilateral, patchy ground-glass opacities, fine reticulation, and traction airway dilatation, with a clear lower zone predominance visible in the sagittal reconstruction. Panel C displays an Organizing Pneumonitis (OP) pattern, showing patchy, peripheral, and basal-predominant lung consolidation. Panel D demonstrates a Usual Interstitial Pneumonitis (UIP) pattern, featuring advanced fibrotic changes including subpleural and basal-predominant reticulation and extensive honeycombing. These images serve as an educational comparison of radiological manifestations in connective tissue disease-related ILD (CTD-ILD), highlighting key diagnostic features such as ground-glass opacification, architectural distortion, and honeycombing across different pathological patterns in patients with anti-Jo1 antibodies.

This diagnostic image consists of two axial high-resolution computed tomography (HRCT) scans of the human chest, demonstrating various patterns of interstitial lung abnormalities (ILAs). The upper panel displays a 'honeycombing-like lesion' characterized by clustered, cystic airspaces with thick, well-defined walls, primarily located in the subpleural and peripheral regions of the lower lung lobes. The lower panel illustrates 'reticular shadows' and 'ground-glass opacities.' The reticular pattern is visible as a fine network of linear opacities, while the ground-glass opacities present as a hazy increase in lung density that does not obscure the underlying bronchovascular structures. These findings are significant in the context of chronic obstructive pulmonary disease (COPD) and the progression of interstitial fibrosis. The imaging serves as a clinical reference for distinguishing specific radiological morphologies in pulmonology and radiology, specifically focusing on the diagnostic criteria for identifying early or comorbid interstitial changes in chronic lung disease patients.
sarcoidosis bilateral hilar lymphadenopathy chest xray

A posteroanterior (PA) chest radiograph demonstrating bilateral hilar enlargement, a classic radiological sign often associated with Stage I sarcoidosis. The image shows well-defined, lobulated opacities in both the left and right hilar regions, representing hilar lymphadenopathy. A white arrow specifically highlights the right hilar adenopathy. The lung parenchyma appears relatively clear with no obvious interstitial markings or focal consolidations. The mediastinal contour is slightly widened, likely due to paratracheal lymphadenopathy. Heart size is within normal limits, and the costophrenic angles are sharp, indicating no pleural effusion. The trachea is midline, and the bony structures, including the clavicles and ribs, appear intact. This diagnostic image is a key educational example for medical students learning the differential diagnosis of bilateral hilar lymphadenopathy, which includes sarcoidosis, lymphoma, and certain infections.

This diagnostic image is an anteroposterior chest X-ray demonstrating a classic presentation of bilateral hilar lymphadenopathy. The primary finding is the symmetrical enlargement of the hilar regions, appearing as lobulated, increased-density masses where the major bronchi and pulmonary vessels enter the lung parenchyma. This 'potato-node' appearance is a hallmark of pulmonary sarcoidosis. The lung fields are generally clear without obvious parenchymal infiltrates or consolidation, though the hilar margins are ill-defined due to the lymphatic enlargement. The mediastinal borders are slightly widened, but the cardiac silhouette and diaphragmatic contours remain distinguishable. The ribcage and clavicles are visualized and provide anatomical orientation. Clinically, this imaging is characteristic of Stage I sarcoidosis, often used to evaluate systemic granulomatous disease in both radiology and internal medicine education.

This diagnostic image is a posteroanterior (PA) chest radiograph demonstrating bilateral hilar lymphadenopathy. Two prominent blue arrows indicate symmetrical enlargement of the lymph nodes in the right and left hilar regions. These enlarged nodes appear as lobulated, increased opacities with well-defined lateral borders, typical of the 'potato nodes' appearance often seen in sarcoidosis. The lung parenchyma appears relatively clear with no visible consolidation, nodules, or interstitial thickening. The mediastinal silhouette is intact, although the paratracheal regions should be evaluated for concomitant adenopathy. The cardiac shadow is within normal limits in size and contour, and the costophrenic angles are sharp, indicating no pleural effusion. This radiographic presentation is a classic finding for Stage I sarcoidosis, providing a key diagnostic feature for medical students and clinicians in identifying granulomatous diseases or lymphoma. The clinical significance lies in recognizing the symmetrical distribution, which helps differentiate sarcoidosis from asymmetrical or unilateral causes of hilar enlargement such as malignancy or tuberculosis.
IPF usual interstitial pneumonia honeycombing traction bronchiectasis HRCT basal

High-resolution computed tomography (HRCT) axial section of the thorax demonstrating a definitive Usual Interstitial Pneumonia (UIP) pattern in a patient with Idiopathic Pulmonary Fibrosis (IPF). The image reveals classic radiologic hallmarks of advanced interstitial lung disease, primarily characterized by extensive honeycombing. These cystic airspaces are predominantly subpleural and basal in distribution, appearing as clustered, thick-walled, lucent cavities of varying sizes. Associated reticular opacities and architectural distortion of the lung parenchyma are evident, indicating chronic fibrotic changes. Traction bronchiectasis may be inferred from the irregular airway dilatation within the fibrotic zones. The mediastinal structures appear grossly normal. This visual presentation is highly characteristic of restrictive lung disease, which clinically correlates with impaired gas exchange and reduced lung compliance.

This transverse High-Resolution Computed Tomography (HRCT) axial scan of the thorax demonstrates a 'definite Usual Interstitial Pneumonia (UIP)' pattern, a hallmark of Idiopathic Pulmonary Fibrosis (IPF). The image shows bilateral, predominantly subpleural and basal lung involvement. Key diagnostic features include honeycombing—manifesting as clustered cystic airspaces with thick walls—which is particularly evident in the subpleural region of the left lung. Associated findings include a prominent reticular pattern, traction bronchiectasis (dilatation of bronchi within the fibrotic areas), and mild ground-glass opacities. The distribution is peripheral and basal-predominant, which is characteristic of the ATS/ERS/JRS/ALAT guidelines for diagnosing UIP. This imaging is crucial for medical students and radiologists to distinguish between different patterns of interstitial lung disease (ILD), specifically identifying the architectural distortion and honeycombing required for a definite diagnosis of UIP versus non-specific interstitial pneumonia (NSIP).

This diagnostic image consists of two high-resolution computed tomography (HRCT) axial scans of the chest demonstrating chronic fibrosing idiopathic interstitial pneumonias (IIPs). Panel (a) illustrates a Usual Interstitial Pneumonia (UIP) pattern, characterized by significant architectural distortion, irregular reticular opacities, and prominent macrocystic honeycombing in the basal and subpleural regions (indicated by a black oval). Traction bronchiectasis is visible (black arrow), along with limited, non-prevalent ground-glass opacities (white arrow). Panel (b) illustrates a Non-Specific Interstitial Pneumonia (NSIP) pattern. This is characterized by bilateral, diffuse, and basal ground-glass opacities. A key diagnostic feature shown is the relative sparing of the subpleural pulmonary parenchyma (indicated by white dotted arrows). Additional findings in panel (b) include irregular reticular opacities and traction bronchiectasis (black arrow). These images serve as a comparative educational resource for identifying radiological hallmarks that differentiate IPF/UIP from NSIP, focusing on the distribution of fibrosis, the presence of honeycombing, and subpleural sparing.
ILD
├── IDIOPATHIC INTERSTITIAL PNEUMONIAS (IIPs)
│ ├── Chronic Fibrosing
│ │ ├── Idiopathic Pulmonary Fibrosis (IPF)
│ │ └── Nonspecific Interstitial Pneumonia (NSIP)
│ ├── Smoking-Related
│ │ ├── Respiratory Bronchiolitis-ILD (RB-ILD)
│ │ └── Desquamative Interstitial Pneumonia (DIP)
│ ├── Acute/Subacute
│ │ ├── Cryptogenic Organizing Pneumonia (COP)
│ │ └── Acute Interstitial Pneumonia (AIP)
│ └── Rare: LIP, PPFE, AFOP
│
├── CONNECTIVE TISSUE DISEASE-ASSOCIATED ILD (CTD-ILD)
│ ├── Systemic Sclerosis (most common)
│ ├── Rheumatoid Arthritis
│ ├── SLE
│ ├── Polymyositis/Dermatomyositis
│ ├── Sjögren Syndrome
│ └── Mixed CTD
│
├── HYPERSENSITIVITY PNEUMONITIS (HP)
│ ├── Farmer's lung, Bird fancier's lung, etc.
│
├── DRUG-INDUCED ILD
│ └── Amiodarone, methotrexate, nitrofurantoin, bleomycin
│
├── OTHER SPECIFIC FORMS
│ ├── Sarcoidosis
│ ├── Langerhans Cell Histiocytosis
│ └── Lymphangioleiomyomatosis (LAM)
│
└── INHERITED FORMS
└── Familial IPF, Tuberous sclerosis, Niemann-Pick, Gaucher

| Term | Appearance | Meaning |
|---|---|---|
| Ground-glass opacity (GGO) | Hazy increased density; vessels still visible | Active inflammation, potentially reversible |
| Reticulation | Network of fine lines | Interstitial thickening; often fibrotic |
| Honeycombing | Clustered cystic spaces with thick walls, subpleural | Established, irreversible fibrosis |
| Traction bronchiectasis | Irregular airway dilation within fibrotic tissue | Advanced fibrosis pulling airways open |
| Consolidation | Dense opacity obscuring vessels | Air-space filling |
| Nodules | Discrete opacities | Granulomas, metastases, infections |
| Mosaic attenuation | Geographic patchy density differences | Air trapping (small airway disease) |
| Septal thickening | Visible interlobular septa | Lymphangitis, edema, early fibrosis |



| Stage | CXR Findings | Spontaneous Remission |
|---|---|---|
| 0 | Normal CXR | - |
| I | Bilateral hilar lymphadenopathy (BHL) only | 60-80% |
| II | BHL + pulmonary infiltrates | 50-60% |
| III | Pulmonary infiltrates only (no LN) | 10-20% |
| IV | Advanced fibrosis, bullae, distortion | <5% (irreversible) |
| Disease | Antigen | Source |
|---|---|---|
| Farmer's lung | Thermophilic actinomycetes, Faeni rectovirgula | Moldy hay, silage, grain |
| Bird fancier's lung | Bird serum/droppings proteins | Pigeons, parakeets, poultry |
| Humidifier lung | Thermoactinomyces vulgaris | Air-conditioning, humidifiers |
| Hot tub lung | Mycobacterium avium complex | Contaminated hot tubs |
| Bagpipe/trombone lung | Fusarium, Candida, Penicillium spp | Instrument reservoirs |
| Metalworking fluid lung | M. immunogenum, Pseudomonas | Industrial metalworking fluid |
| Cheese washer's lung | Penicillium casei | Cheese |
| Mushroom worker's lung | Thermoactinomyces sacchari | Mushroom compost |
| Phase | Time after exposure | Histology |
|---|---|---|
| Acute | Hours-days | Alveolar damage, neutrophil infiltration |
| Subacute | Weeks-months | Interstitial pneumonitis (lymphocytes, plasma cells), non-caseating granulomas, bronchiolocentric |
| Chronic/Fibrotic | Years | Fibrosis (UIP or NSIP pattern), honeycombing, obliterative bronchiolitis |
| CTD | ILD prevalence | Most common histological pattern |
|---|---|---|
| Systemic Sclerosis (SSc) | 50% diffuse, 30% limited | NSIP (most common), also UIP |
| Polymyositis/Dermatomyositis | 30-40% | NSIP, also COP |
| Rheumatoid Arthritis (RA) | 10-30% | UIP (often indistinguishable from IPF) |
| Sjögren Syndrome | 10-25% | LIP (lymphoid interstitial pneumonia) |
| SLE | <10% clinically significant | NSIP, DAD, COP |
| Mixed CTD | 50-67% | NSIP |
| Drug | Pattern | Notes |
|---|---|---|
| Amiodarone | NSIP, COP, DAD | Most common; check CXR/HRCT at baseline and annually |
| Methotrexate | HP-like, COP | Usually reversible on stopping |
| Bleomycin | NSIP, DAD | Dose-dependent; avoid high FiO2 (worsens) |
| Nitrofurantoin | Acute: DAD; Chronic: NSIP | Two distinct syndromes |
| Immunotherapy (checkpoint inhibitors) | Pneumonitis | Increasingly common; may be severe |
| Radiation | Radiation pneumonitis → fibrosis | Confined to radiation field |
Step 1: HISTORY
- Duration and pace (acute/subacute/chronic)
- Occupational: dust, birds, mold, metal, chemicals
- Medications, radiation, smoking
- Autoimmune symptoms: joint pain, Raynaud's, skin changes, sicca, myositis
- Family history
Step 2: EXAMINATION
- Velcro crackles (bibasal)
- Clubbing (IPF > others)
- Signs of CTD: arthritis, skin thickening, telangiectasia, myositis
Step 3: INVESTIGATIONS
- CXR (initial, often non-specific)
- HRCT chest (most important imaging)
- PFT: restrictive pattern + DLCO ↓
- Bloods: FBC, LFTs, U&E, CRP, ESR
- Autoimmune screen: ANA, RF, anti-CCP, anti-Scl70, anti-Jo-1, anti-dsDNA, myositis panel
- Serum precipitins (if HP suspected)
- 6-minute walk test (exercise capacity)
Step 4: BRONCHOSCOPY (if diagnosis unclear)
- BAL: cell differential
· Lymphocytosis → sarcoidosis, HP, NSIP, COP
· Neutrophilia → IPF, infection
· Eosinophilia → eosinophilic pneumonia
· Hemosiderin-laden macrophages → alveolar hemorrhage
- Transbronchial biopsy (good for sarcoidosis, less useful for fibrotic ILD)
Step 5: SURGICAL BIOPSY (if still uncertain)
- VATS (video-assisted thoracoscopic surgery) biopsy
- Multiple biopsies from different lobes
- Avoid areas of dense fibrosis (sample the "active edge")
- MDT discussion: pulmonologist + radiologist + pathologist
| Cell Predominance | Think |
|---|---|
| Lymphocytes (>15%) | Sarcoidosis (CD4:CD8 ↑), HP (CD4:CD8 ↓), NSIP, COP |
| Neutrophils | IPF, infection, acute HP, ARDS |
| Eosinophils | Eosinophilic pneumonia, drug reaction |
| Macrophages with lipid | Aspiration, DIP, RB-ILD |
| Hemosiderin macrophages | Alveolar hemorrhage, Goodpasture, vasculitis |
| Condition | FVC | TLC | DLCO | Special Note |
|---|---|---|---|---|
| IPF | ↓↓ | ↓↓ | ↓↓ | DLCO often disproportionately low |
| NSIP | ↓ | ↓ | ↓ | Better preserved than IPF |
| Sarcoidosis | ↓ (variable) | ↓ | ↓ | Can also have obstruction (endobronchial) |
| HP (chronic) | ↓ | ↓ | ↓ | Obstruction possible (air trapping) |
| COP | ↓ | ↓ | ↓ | Dramatic improvement with steroids |
| LAM | ↓ + obstruction | ↑ RV | ↓ | Mixed pattern; cysts trap air |
| SSc-ILD | ↓ | ↓ | ↓ | Isolated DLCO ↓ may indicate PAH |
| Finding | Disease |
|---|---|
| Velcro crackles + clubbing + basilar honeycombing + male smoker >60 | IPF |
| Young woman + recurrent pneumothorax + diffuse lung cysts | LAM |
| Farmer / bird keeper + acute flu-like illness after exposure | HP |
| Bilateral hilar LN + non-caseating granulomas + erythema nodosum | Sarcoidosis Stage I / Lofgren |
| Non-smoker female + GGO + subpleural sparing + positive ANA | CTD-ILD (NSIP pattern) |
| Consolidation that doesn't respond to antibiotics | COP |
| Young heavy smoker + upper lobe cysts + nodules | PLCH |
| Pulmonary hemorrhage + nephritis | Goodpasture / ANCA vasculitis |
| Amiodarone use + new opacities | Drug-induced ILD |
| Scleroderma patient with low DLCO out of proportion to FVC | Pulmonary Arterial Hypertension complicating SSc-ILD |